A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

AAOS Announces 2021 MORE Award Recipients

The American Academy of Orthopaedic Surgeons (AAOS) is pleased to announce the recipients of the 2021 Media Orthopaedic Reporting Excellence (MORE) Awards. Presented annually to U.S.-based journalists, the MORE Awards acknowledge accurate reporting of musculoskeletal health news topics and celebrate the role media play in accurately educating and informing patients about musculoskeletal health issues, innovative bone and joint treatments, preventative care and patient recovery.

Entries were judged by a panel of orthopaedic surgeons and evaluated for overall quality and medical accuracy. The winners of the 2021 awards include health and medical writers, photographers and freelance reporters from print, broadcast and online media outlets. From heart-warming patient stories to perspectives on orthopaedic innovations and treatment options, the award recipients covered an array of bone and joint-health topics.

“Having trusted sources of information that increase the public’s knowledge of bone and joint conditions and issues that impact patient care is important,” said Daniel K. Guy, MD, FAAOS, AAOS President. “We gratefully acknowledge the media’s commitment to delivering compelling and accurate reporting. The AAOS is honored to sponsor the MORE Awards, a long-standing program that recognizes the positive impact that journalism plays in sharing stories of patients’ perseverance and their successes.”

The 2021 MORE Award winners by category are:

Newspaper/Magazine Feature

Broadcast Feature

Online Journalism

The AAOS has bestowed more than 300 MORE Awards since the program’s inception in 2006.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.
“We are excited to present the first look at the safety and clinical activity of ELVN-001, which we believe supports the potential for ELVN-001 to address the limitations of the available active-site TKIs,” said Helen Collins, M.D., Chief Medical Officer of Enliven. “Across a wide dose range, ELVN-001 demonstrated activity in a heavily pre-treated patient population that includes post-asciminib patients, with a preliminary safety profile consistent with its highly selective design. Not only did all evaluable patients have improved or stable BCR::ABL1 transcript levels, but, importantly, 89% of all patients enrolled remain on study. We believe the initial data demonstrate the potential clinical utility of ELVN-001 for all types of patients, including those that are earlier in the treatment paradigm.”
The partnership is with Health-HavenRx ™, an online pharmacy platform. This partnership enables a new, convenient channel for patients to access POGO Automatic by using their health insurance on Intuity Medical’s e-commerce website at www.GoodtoPogo.com.

By using this website you agree to accept Medical Device News Magazine Privacy Policy